CCRVDF

European Union comments on:

CL 2025/47-PR/RVDF: Request for comments on the harmonization of food descriptors for commodities of animal origin used by CCPR and CCRVDF
CL 2025/48-PR/RVDF: Request for comments on harmonizing Codex maximum residue limits for dual-use compounds

28th Session

European Union comments on:

Agenda item 6: Request for comments at Step 6 on the MRLs for fumagillin DCH in finfish (filet) and honey (CL 2026/10-RVDF)
Agenda item 7.2: Extrapolation of MRLs for veterinary drugs to edible offal tissues other than liver and kidney (CL 2025/12-RVDF)
Agenda Item 8.1: Guidelines action levels (CL 2026/13-RVDF)
Agenda Item 8.2: Action levels for nicarbazin and lasalocid in chicken eggs due to unavoidable and unintentional carryover in feed (CL 2026/14-RVDF)
Agenda item 9: Coordination of work between CCPR and CCRVDF
Agenda item 10: Priority list of veterinary drugs for evaluation or re-evaluation by JECFA (CL 2026/15-RVDF)

European Union comments on:

Agenda item 8: Criteria and procedures for the establishment of action levels for veterinary drugs in food of animal origin resulting from unavoidable and unintentional veterinary drug carry-over in non-target animal feed
Agenda item 9: Coordination of work between CCPR and CCRVDF
CL 2024/65-RVDF: Maximum Residue Limits for Veterinary Drugs in Foods

European Union comments on:

Agenda item 6: MRLs for veterinary drugs in foods. (CL 2022/71-RVDF)
Agenda Item 7: Extrapolation of MRLs for veterinary drugs in foods) (CL 2022/76-RVDF)
Agenda Item 8: Criteria and procedures for the establishment of action levels for unintended and unavoidable carryover of veterinary drugs (CL 2022/77-RVDF)
Agenda item 9.1: RVDF recommendations arising from the Joint CCPR/CCRVF Electronic Working Group (CL 2022/78 -RVDF)

European Union comments on:

CL 2021/02-RVDF on the recommendations for the further steps on the use and maintenance of the database on countries’ needs for maximum residue limits for veterinary drugs in foods.
CL 2021/05-RVDF on the principles and procedure for the parallel review of a new veterinary drug by JECFA and national regulatory agencies.

European Union reply to:

CL 2020/42-RVDF:
1. The approach for the extrapolation of maximum residue limits for veterinary drugs to one or more species.
2. The proposals for MRLs based on the approach proposed for extrapolation of MRLs to one or more species.
CL 2020/17-RVDF: "Maximum residue limits for veterinary drugs".

European Union comments on:

Agenda Item 6.2: Proposed draft MRLs for amoxicillin (finfish fillet, muscle); ampicillin (finfish fillet, muscle); flumethrin (honey), lufenuron (salmon and trout fillet), monepantel (cattle fat, kidney, liver, muscle) (CX/RVDF 18/24/6).
Agenda Item 10: Discussion paper on the evaluation of the rationale for the decline in new compounds to be included in the ccrvdf priority list for evaluation by JECFA (CX/RVDF 18/24/10).
CL 2016/41-RVDF: Priority List of Veterinary Drugs for Evaluation or Re-evaluation by JECFA
CL 2017/72-RVDF: Draft Risk Management Recommendation (RMR) for gentian violet
CL 2016/38-RVDF: Proposed draft MRLs for lasalocid sodium, ivermectin and teflubenzuron at step 5/8
CL 2016/39-RVDF: Proposed Draft RMR for Gentian Violet at Step 5

European Union comments on:

Agenda item 5: Proposed Draft RMR for gentian violet at Step 3 (CL 2015/14-RVDF, Part B).
Agenda item 6: Proposed draft MRLs for ivermectin, teflubenzuron and lasalocid sodium.

European Union comments on:

Agenda item 3: Matters Referred by the Codex Alimentarius Commission and other Committees - Codex Strategic Plan 2014-2019 (CX/RVDF 15/22/3).
Agenda item 6c: Proposed draft MRLs for derquantel, emamectin benzoate, ivermectin, lasalocid sodium and monepantel (CX/RVDF 15/22/6) and 'concern form' from for Lasalocid sodium.
Agenda item 6d: Proposed draft RMRs for dimitridazole, ipronidazole, metronidazole and ronidazole.

European Union reply to: